Emergence of two unrelated clones in acute myeloid leukemia with MLL-SEPT9 fusion transcript

Cancer Genetics and Cytogenetics

Volumn 201, Issue 2, 2010, Pages 111-115

  Saito, Hajime ^a   Otsubo, Kaori ^b   Kakimoto, Atsushi ^b   Komatsu, Norio ^c   Ohsaka, Akimichi ^c  

^a Mitochuo Hospital   (Japan)

^b SRL INC   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACLARUBICIN; CYTARABINE; DAUNORUBICIN; ENOCITABINE; ETOPOSIDE; GYRASE INHIBITOR; IDARUBICIN; MITOXANTRONE; MIXED LINEAGE LEUKEMIA PROTEIN; ONCOPROTEIN; PROTEIN SEPT9; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER RELAPSE; CASE REPORT; CHROMOSOME ABERRATION; FLOW CYTOMETRY; GENE FUSION; GENE SEQUENCE; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; MALE; MOLECULAR CLONING; PANCYTOPENIA; PNEUMONIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

EID: 77955244085     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.05.016     Document Type: Article

References (22)

1. Dou Y., Hess J.L. Mechanisms of transcriptional regulation by MLL and its disruption in acute leukemia. Int J Hematol 2008, 87:10-18.
2. Rodriguez-Perales S., Cano F., Lobato M.N., Rabbitts T.H. MLL gene fusions in human leukaemias: in vivo modelling to recapitulate these primary tumourigenic events. Int J Hematol 2008, 87:3-9.
3. Meyer C., Kowarz E., Hofmann J., Renneville A., Zuna J., Trka J., et al. New insights to the MLL recombinome of acute leukemias. Leukemia 2009, 23:1490-1499.
4. Hall P.A., Russell S.E. The pathobiology of the septin gene family. J Pathol 2004, 204:489-505.
5. McIlhatton M.A., Burrows J.F., Donaghy P.G., Chanduloy S., Johnston P.G., Russell S.E. Genomic organization, complex splicing pattern and expression of a human septin gene on chromosome 17q25.3. Oncogene 2001, 20:5930-5939.
6. Peterson E.A., Kalikin L.M., Steels J.D., Estey M.P., Trimble W.S., Petty E.M. Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin. Mamm Genome 2007, 18:796-807.
7. Russell S.E., Hall P.A. Do septins have a role in cancer?. Br J Cancer 2005, 93:499-503.
8. Santos J., Cerveira N., Bizarro S., Ribeiro F.R., Correia C., Torres L., et al. Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes. Leuk Res 2010, 34:615-621.
9. Osaka M., Rowley J.D., Zeleznik-Le N.J. MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). Proc Natl Acad Sci U S A 1999, 96:6428-6433.
10. Taki T., Ohnishi H., Shinohara K., Sako M., Bessho F., Yanagisawa M., et al. AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17)(q23;q25). Cancer Res 1999, 59:4261-4265.
11. Macara I.G., Baldarelli R., Field C.M., Glotzer M., Hayashi Y., Hsu S.C., et al. Mammalian septins nomenclature. Mol Biol Cell 2002, 13:4111-4113.
12. Yamamoto K., Shibata F., Yamaguchi M., Miura O. Fusion of MLL and MSF in adult de novo acute myelomonocytic leukemia (M4) with t(11;17)(q23;q25). Int J Hematol 2002, 75:503-507.
13. Strehl S., König M., Meyer C., Schneider B., Harbott J., UJäger U., et al. Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants. Genes Chromosomes Cancer 2006, 45:1041-1049.
14. Kreuziger L.M., Porcher J.C., Ketterling R.P., Steensma D.P. An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndrome. Leuk Res 2007, 31:1145-1148.
15. Kurosu T., Tsuji K., Ohki M., Miki T., Yamamoto M., Kakihana K., et al. A variant-type MLL/SEPT9 fusion transcript in adult de novo acute monocytic leukemia (M5b) with t(11;17)(q23;q25). Int J Hematol 2008, 88:192-196.
16. Santos J., Cerveira N., Correia C., Lisboa S., Pinheiro M., Torres L., et al. Coexistence of alternative MLL-SEPT9 fusion transcripts in an acute myeloid leukemia with t(11;17)(q23;q25). Cancer Genet Cytogenet 2010, 197:60-64.
17. Ohsaka A., Otsubo K., Yokota H., Hisa T., Saito H., Kozaki T. Spectral karyotyping and fluorescence in situ hybridization analyses identified a novel three-way translocation involving inversion 16 in therapy-related acute myeloid leukemia M4eo. Cancer Genet Cytogenet 2008, 184:113-118.
18. Olney H.J., Mitelman F., Johansson B., Mrózek K., Berger R., Rowley J.D. Unique balanced chromosome abnormalities in treatment-related myelodysplastic syndromes and acute myeloid leukemia: report from an international workshop. Genes Chromosomes Cancer 2002, 33:413-423.
19. So C.W., Lin M., Ayton P.M., Chen E.H., Cleary M.L. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. Cancer Cell 2003, 4:99-110.
20. Martin M.E., Milne T.A., Bloyer S., Galoian K., Shen W., Gibbs D., et al. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell 2003, 4:197-207.
21. Johansson B., Billström R., Broberg K., Fioretos T., Nilsson P.G., Ahlgren T., et al. Cytogenetic polyclonality in hematologic malignancies. Genes Chromosomes Cancer 1999, 24:222-229.
22. Han J.Y., Theil K.S., Hoeltge G. Frequencies and characterization of cytogenetically unrelated clones in various hematologic malignancies: seven years of experiences in a single institution. Cancer Genet Cytogenet 2006, 164:128-132.